MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 8.491
AS - Asia 3.458
EU - Europa 1.978
SA - Sud America 571
AF - Africa 47
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.551
Nazione #
US - Stati Uniti d'America 8.353
SG - Singapore 1.356
CN - Cina 1.053
UA - Ucraina 517
BR - Brasile 484
DE - Germania 353
TR - Turchia 347
HK - Hong Kong 337
GB - Regno Unito 281
VN - Vietnam 184
PL - Polonia 162
IT - Italia 155
FI - Finlandia 131
SE - Svezia 121
RU - Federazione Russa 91
MX - Messico 73
FR - Francia 60
CA - Canada 50
IN - India 36
BE - Belgio 34
AR - Argentina 30
ZA - Sudafrica 29
ID - Indonesia 27
NL - Olanda 23
BD - Bangladesh 19
JP - Giappone 19
IQ - Iraq 14
CL - Cile 12
CO - Colombia 12
ES - Italia 12
EC - Ecuador 11
IR - Iran 10
LT - Lituania 9
UZ - Uzbekistan 8
RO - Romania 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
KR - Corea 6
MA - Marocco 6
PE - Perù 6
PK - Pakistan 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
PY - Paraguay 5
JM - Giamaica 4
KE - Kenya 4
KG - Kirghizistan 4
CH - Svizzera 3
EG - Egitto 3
IL - Israele 3
NP - Nepal 3
UY - Uruguay 3
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
JO - Giordania 2
NZ - Nuova Zelanda 2
PA - Panama 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GM - Gambi 1
GY - Guiana 1
HU - Ungheria 1
IE - Irlanda 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 14.551
Città #
Woodbridge 897
Fairfield 876
Ashburn 789
Singapore 782
Houston 582
Jacksonville 563
Ann Arbor 502
Chandler 433
Santa Clara 359
Beijing 342
Hong Kong 336
Seattle 336
Wilmington 310
Dallas 293
Cambridge 252
Izmir 174
Nanjing 170
Warsaw 157
Dearborn 127
Princeton 107
Los Angeles 106
San Diego 104
Boardman 74
Addison 68
Ho Chi Minh City 68
New York 66
São Paulo 59
Mexico City 53
Milan 50
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Hanoi 43
Shanghai 38
Ferrara 37
Hebei 35
Brussels 34
Brooklyn 33
Jiaxing 29
Washington 28
Tianjin 27
London 26
Chicago 25
Jinan 23
San Mateo 23
Falkenstein 22
Auburn Hills 21
San Francisco 21
Turku 21
Bremen 19
Changsha 19
Tokyo 19
Kunming 18
Rio de Janeiro 18
Mountain View 16
Phoenix 16
Zhengzhou 16
Johannesburg 15
Moscow 15
Toronto 15
Boston 14
Buffalo 14
Jakarta 14
Stockholm 14
Frankfurt am Main 13
Poplar 13
Chennai 12
Council Bluffs 12
Falls Church 12
Montreal 12
Norwalk 12
Ningbo 11
Orem 11
Belo Horizonte 10
Denver 10
Dong Ket 10
Helsinki 10
Manchester 10
Porto Alegre 10
Amsterdam 9
Atlanta 9
Des Moines 9
Haiphong 9
Indiana 9
Redwood City 9
The Dalles 9
Columbus 8
Da Nang 8
Guangzhou 8
Orange 8
Philadelphia 8
Ardabil 7
Augusta 7
Maringá 7
Ottawa 7
Ankara 6
Baghdad 6
Charlotte 6
Rome 6
Totale 10.273
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 342
A cyclic peptide T analogue with high chemotactic activity 259
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 217
Arecoline tripeptide inhibitors of proteasome 206
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 196
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 185
Vinyl ester-based cyclic peptide proteasome inhibitors 184
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 183
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 183
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 182
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 179
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 178
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 176
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 172
A Bioactive Fullerene Peptide 171
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 170
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 170
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 170
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 169
A 500 MHz study of peptide T in a DMSO solution 169
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 167
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 166
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 164
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 162
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 162
Conformational analysis of peptide T and of its C‐pentapeptide fragment 162
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 161
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 160
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 159
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 158
Structure–activity relationships of cyclic and linear peptide T analogues 157
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 155
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 153
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 152
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 150
Synthesis and biological activity of carboxyl terminally extended dermorphins 149
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 147
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 146
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 146
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 144
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 144
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 144
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 143
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 142
Anodic mineralization of pentachlorophenol in alkaline media 141
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 141
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 140
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 138
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 136
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 134
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 134
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 133
New cyclic peptide proteasome inhibitors 133
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 130
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 130
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 129
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 129
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 129
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 128
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 126
Conformational properties of deltorphin: new features of the delta-opioid receptors 126
Synthesis and structure activity relationships of delthorphine analogues 121
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 120
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 120
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 116
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 116
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 113
Opioid peptides. Partially modified retro-inverso dermorphin analogues 113
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 110
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 109
null 107
null 107
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 106
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 105
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 103
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 103
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 103
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 102
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 102
Synthesis and activity of new linear and cyclic peptide T derivatives 101
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 101
Peptide-based molecules for the production of positive charged liposomes and micelles 100
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 100
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 100
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 100
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 99
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 99
Synthesis and biological activity of chelator-peptide T conjugates 97
null 96
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 93
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 91
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 90
null 90
null 90
null 89
null 87
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 87
Structure-activity relationships of peptide T-related pentapeptides 87
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 86
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 86
Totale 13.756
Categoria #
all - tutte 66.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.097
Totale 67.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021819 0 0 0 0 0 144 53 156 27 181 189 69
2021/20221.267 44 91 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20263.371 652 290 733 745 772 179 0 0 0 0 0 0
Totale 14.656